Genmab A/S (OTCMKTS:GNMSF) Share Price Passes Below Two Hundred Day Moving Average of $296.92

Shares of Genmab A/S (OTCMKTS:GNMSFGet Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $296.92 and traded as low as $291.08. Genmab A/S shares last traded at $301.97, with a volume of 856 shares.

Genmab A/S Stock Down 0.2 %

The firm has a fifty day moving average of $292.08 and a two-hundred day moving average of $297.10.

Genmab A/S (OTCMKTS:GNMSFGet Free Report) last issued its earnings results on Thursday, May 2nd. The company reported $2.94 earnings per share for the quarter. Genmab A/S had a net margin of 30.74% and a return on equity of 20.80%. The firm had revenue of $603.22 million during the quarter.

Genmab A/S Company Profile

(Get Free Report)

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.

Featured Articles

Receive News & Ratings for Genmab A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genmab A/S and related companies with MarketBeat.com's FREE daily email newsletter.